Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-15 7:26 pm Purchase | 13D | ONCOCYTE CORP COM OCX | BROADWOOD PARTNERS L.P. | 5,079,316 37.6% | 5,079,316 (New Position) | View |
| 2024-02-08 6:57 pm Purchase | 13D | LINEAGE CELL THERAPEUTICS INC LCTX | BROADWOOD PARTNERS L.P. | 41,983,883 22.2% | 6,756,610 (+19.18%) | View |
| 2024-01-10 5:23 pm Purchase | 13D | STAAR SURGICAL CO STAA | BROADWOOD PARTNERS L.P. | 10,794,330 22.1% | 665,586 (+6.57%) | View |
| 2023-11-15 5:27 pm Purchase | 13D | STAAR SURGICAL CO STAA | BROADWOOD PARTNERS L.P. | 10,128,744 20.7% | 633,121 (+6.67%) | View |
| 2023-10-10 08:00 am Purchase | 13D | STAAR SURGICAL CO STAA | BROADWOOD PARTNERS L.P. | 9,495,623 19.6% | 877,716 (+10.18%) | View |
| 2023-04-07 10:38 am Purchase | 13D | ONCOCYTE CORPORATION OCX | BROADWOOD PARTNERS L.P. | 57,131,187 33.3% | 26,918,288 (+89.10%) | View |
| 2022-07-28 5:06 pm Purchase | 13D | ONCOCYTE CORPORATION OCX | BROADWOOD PARTNERS L.P. | 30,212,899 24.1% | 6,437,935 (+27.08%) | View |
| 2022-04-15 5:21 pm Purchase | 13D | ONCOCYTE CORPORATION OCX | BROADWOOD PARTNERS L.P. | 23,774,964 19.99% | 5,939,374 (+33.30%) | View |
| 2022-03-25 5:23 pm Purchase | 13D | LINEAGE CELL THERAPEUTICS INC LCTX | BROADWOOD PARTNERS L.P. | 35,227,273 20.7% | 980,106 (+2.86%) | View |
| 2021-10-01 4:59 pm Sale | 13D | STAAR SURGICAL CO STAA | BROADWOOD PARTNERS L.P. | 8,617,907 18.2% | -408,350 (-4.52%) | View |
| 2021-09-24 4:40 pm Unchanged | 13D | ONCOCYTE CORPORATION OCX | BROADWOOD PARTNERS L.P. | 17,835,590 19.3% | 0 (Unchanged) | View |
| 2021-06-15 8:46 pm Sale | 13D | STAAR SURGICAL CO STAA | BROADWOOD PARTNERS L.P. | 9,026,257 19.2% | -443,734 (-4.69%) | View |
| 2021-04-05 5:12 pm Sale | 13D | STAAR SURGICAL CO STAA | BROADWOOD PARTNERS L.P. | 9,469,991 20.3% | -455,931 (-4.59%) | View |
| 2021-03-16 5:04 pm Purchase | 13D | LINEAGE CELL THERAPEUTICS INC LCTX | BROADWOOD PARTNERS L.P. | 34,247,167 21.2% | 34,247,167 (New Position) | View |
| 2021-02-09 5:10 pm Purchase | 13D | ONCOCYTE CORPORATION OCX | BROADWOOD PARTNERS L.P. | 17,835,590 20.1% | 600,000 (+3.48%) | View |
| 2021-01-28 5:25 pm Sale | 13D | STAAR SURGICAL CO STAA | BROADWOOD PARTNERS L.P. | 9,925,922 21.5% | -895,326 (-8.27%) | View |
| 2021-01-22 4:18 pm Purchase | 13D | ONCOCYTE CORPORATION OCX | BROADWOOD PARTNERS L.P. | 17,235,590 21.6% | 5,078,217 (+41.77%) | View |
| 2020-08-12 5:05 pm Sale | 13D | STAAR SURGICAL CO STAA | BROADWOOD PARTNERS L.P. | 10,821,248 23.6% | -59,831 (-0.55%) | View |
| 2019-09-13 5:08 pm Purchase | 13D | ONCOCYTE CORPORATION OCX | BROADWOOD PARTNERS L.P. | 12,157,373 22.9% | 2,000,000 (+19.69%) | View |
| 2019-07-02 5:09 pm Purchase | 13D | ONCOCYTE CORPORATION OCX | BROADWOOD PARTNERS L.P. | 10,157,373 19.2% | 1,000,000 (+10.92%) | View |